Company Filing History:
Years Active: 2021
Title: Corinne Cluis: Innovator in Glutathione Production
Introduction
Corinne Cluis is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of biotechnology, particularly in the production of glutathione, a vital antioxidant in cellular processes. Her innovative work has led to the development of a patented technology that enhances the efficiency of glutathione production.
Latest Patents
Corinne Cluis holds a patent for "Optimized host cells for the production of glutathione." This patent involves a genetically modified host cell designed for the production and accumulation of glutathione (GSH). The genetically modified host cell allows for the expression of a mutated Cys4p, which has increased activity. Additionally, the host cell can express a mutated Yap1p, which reduces the translocation from the nucleus to the cytoplasm. Furthermore, it can express a heterologous threonine aldolase (Gly1p). This innovative approach has the potential to significantly improve glutathione production processes.
Career Highlights
Corinne Cluis is currently associated with Lallemand Inc., a company known for its expertise in yeast and bacteria for various applications. Her work at Lallemand Inc. focuses on advancing biotechnological solutions that can benefit various industries, including health and nutrition.
Collaborations
Corinne collaborates with Caroline Wilde, who is also a prominent figure in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in biotechnology.
Conclusion
Corinne Cluis is a pioneering inventor whose work in optimizing glutathione production through genetically modified host cells showcases her commitment to advancing biotechnological solutions. Her contributions are poised to have a lasting impact on the industry.